Clinical trial Recruiting at 1 site Observational Ages 40 to 85

High-frequency spinal cord stimulation for herpes zoster pain relief

Official title: The Efficacy of High-frequency Short-time Spinal Cord Stimulation in the Treatment of Herpes Zoster-associated Neuralgia

Run by Zunyi Medical College · NCT06942806 · Data updated 2026-11-12

This study is testing if high-frequency spinal cord stimulation can help relieve pain for people with shingles who haven't found relief from regular treatments.

Quick facts

Study typeObservational
Ages40 Years to 85 Years
SexAll
Enrollment74 (estimated)
SponsorZunyi Medical College
Academic / other
Locations1 site (Zunyi, Guizhou)
StatusRecruiting
StartedFebruary 1, 2024
Main results expectedMay 31, 2025
Study endsMay 31, 2025
Registry record updatedApril 30, 2025
Trial IDNCT06942806 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with moderate to severe herpes zoster-associated pain who have not responded to non-surgical treatments.

Probably not a fit

Patients with severe psychiatric disorders or those with significant local or systemic infections may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of high-frequency spinal cord stimulation (HF-SCS) in treating herpes zoster-associated neuralgia, a painful condition resulting from the reactivation of the varicella-zoster virus. The research focuses on patients who have not responded adequately to conventional treatments and examines the impact of HF-SCS on pain relief and quality of life. The methodology involves comparing HF-SCS with traditional low-frequency stimulation, assessing various parameters such as frequency, pulse width, and amplitude to optimize pain management. The study aims to provide insights into the mechanisms of pain modulation and the potential benefits of HF-SCS in this patient population.

Why it matters

Potential benefit: If successful, this approach could significantly improve pain management and quality of life for patients suffering from herpes zoster-associated neuralgia.

How similar studies have gone: Previous studies have shown promising results with spinal cord stimulation for neuropathic pain, suggesting potential success for this novel high-frequency approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients with inadequate response to non-surgical treatments such as pharmacotherapy;
2. Patients with major organ dysfunction intolerant to drug therapy;
3. Patients with systemic comorbidities (e.g., hypertension, diabetes mellitus);
4. Patients with moderate to severe pain intensity (Numerical Rating Scale \[NRS\] score ≥ 4).

Exclusion Criteria:

1. Patients with severe psychiatric disorders;
2. Patients with severe local or systemic infections at the puncture site;
3. Patients with severe coagulopathies (platelet count \< 80×10⁹/L during puncture) or those requiring uninterrupted anticoagulation therapy without bridging protocol;
4. Patients with end-stage organ failure who cannot maintain prone positioning or tolerate the procedure;
5. Patients with severe spinal stenosis, vertebral ankylosis, or scoliosis;
6. Patients with language barrier or impaired communication abilities.ion

Where it's running

  • 149 Dalian Road, Huichuan District, Zunyi City, Guizhou Province
    Zunyi, Guizhou, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.